Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin

NCT00736983 is registered in ClinicalTrials.gov with Foundation for Liver Research as lead sponsor.

NCT NCT00736983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin
Lead sponsor
Foundation for Liver Research
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
December 31, 2011
Enrollment
76 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease with perianal fistulas